Libra is currently advancing novel approaches for developmental, immunological, and epithelial disorders.



Libra Biosciences is a life science company focused on the development of novel diagnostic, therapeutic, and consumer products based on the exciting, emerging field of the human microbiome.

Humans harbor trillions of peaceful microbes that live on nearly all of our anatomical surfaces. We have evolved with these microbes to the point where they serve important functions that promote and maintain our health, and protect us from disease. Measurement and modulation of the microbiome’s role in health and disease presents the opportunity to impact medicine and wellness in an entirely new way.

Libra is leveraging cutting-edge microbiome insights to advance novel therapeutics and diagnostics in areas including metabolism, infectious disease, and epithelial disorders. Libra was co-founded by PureTech Ventures together with the world’s leading experts in the related fields.

Libra represents “balance” between all factors that constitute the human organism.

Inquiries: info@librabio.com